Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dong Hyun Choi

Showing results (1-10 of 139) with videos related to

Pageof 14
Sort By:
The Korean Journal of Internal Medicine|November 4, 2016
Mean platelet volume: a potential biomarker of the risk and prognosis of heart diseaseDong-Hyun Choi, Seong-Ho Kang, Heesang Song
Pharmacological Reports : PR|January 9, 2014
Effects of nifedipine on the pharmacokinetics of repaglinide in rats: possible role of CYP3A4 and P-glycoprotein inhibition by nifedipineJin-Seok Choi, In Choi, Dong-Hyun Choi
The Journal of Pharmacy and Pharmacology|July 20, 2010
Effects of myricetin, an antioxidant, on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats: possible role of cytochrome P450 3A4, cytochrome P450 2C9 and P-glycoprotein inhibition by myricetinDong-Hyun Choi, Cheng Li, Jun-Shik Choi
Journal of Pharmacokinetics and Pharmacodynamics|January 3, 2012
Effects of efonidipine on the pharmacokinetics and pharmacodynamics of repaglinide: possible role of CYP3A4 and P-glycoprotein inhibition by efonidipineCheng Li, Dong-Hyun Choi, Jun-Shik Choi
European Journal of Drug Metabolism and Pharmacokinetics|February 20, 2010
Effects of simvastatin on the pharmacokinetics of verapamil and its main metabolite, norverapamil, in ratsDong-Hyun Choi, Cheng Li, Jun-Shik Choi
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 2015
Effects of pioglitazone on the pharmacokinetics of nifedipine and its main metabolite, dehydronifedipine, in ratsJin-Seok Choi, In Choi, Dong-Hyun Choi
Pharmacology|June 29, 2011
Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of losartan and its main metabolite EXP-3174 in rats: possible role of CYP3A4 and P-gp inhibition by HMG-CoA reductase inhibitorsSi-Hyung Yang, Jun-Shik Choi, Dong-Hyun Choi
Research Communications in Molecular Pathology and Pharmacology|July 13, 2004
Pharmacokinetics of tolbutamide after oral administration in rabbits with folate-induced renal failureHak Yeon Bae, Dong Hyun Choi, Jun Shik Choi
European Journal of Clinical Pharmacology|December 17, 2009
Pharmacokinetic interaction between oral lovastatin and verapamil in healthy subjects: role of P-glycoprotein inhibition by lovastatinDong-Hyun Choi, Joong-Hwa Chung, Jun-Shik Choi
Pharmacological Reports : PR|January 7, 2015
Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of nifedipine in rats: Possible role of P-gp and CYP3A4 inhibition by HMG-CoA reductase inhibitorsChong-Ki Lee, Jun-Shik Choi, Dong-Hyun Choi
Pageof 14

Showing results (1-10 of 139) with videos related to

Sort By:
Pageof 14
The Korean Journal of Internal Medicine|November 4, 2016
Mean platelet volume: a potential biomarker of the risk and prognosis of heart diseaseDong-Hyun Choi, Seong-Ho Kang, Heesang Song
Pharmacological Reports : PR|January 9, 2014
Effects of nifedipine on the pharmacokinetics of repaglinide in rats: possible role of CYP3A4 and P-glycoprotein inhibition by nifedipineJin-Seok Choi, In Choi, Dong-Hyun Choi
The Journal of Pharmacy and Pharmacology|July 20, 2010
Effects of myricetin, an antioxidant, on the pharmacokinetics of losartan and its active metabolite, EXP-3174, in rats: possible role of cytochrome P450 3A4, cytochrome P450 2C9 and P-glycoprotein inhibition by myricetinDong-Hyun Choi, Cheng Li, Jun-Shik Choi
Journal of Pharmacokinetics and Pharmacodynamics|January 3, 2012
Effects of efonidipine on the pharmacokinetics and pharmacodynamics of repaglinide: possible role of CYP3A4 and P-glycoprotein inhibition by efonidipineCheng Li, Dong-Hyun Choi, Jun-Shik Choi
European Journal of Drug Metabolism and Pharmacokinetics|February 20, 2010
Effects of simvastatin on the pharmacokinetics of verapamil and its main metabolite, norverapamil, in ratsDong-Hyun Choi, Cheng Li, Jun-Shik Choi
European Journal of Drug Metabolism and Pharmacokinetics|January 1, 2015
Effects of pioglitazone on the pharmacokinetics of nifedipine and its main metabolite, dehydronifedipine, in ratsJin-Seok Choi, In Choi, Dong-Hyun Choi
Pharmacology|June 29, 2011
Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of losartan and its main metabolite EXP-3174 in rats: possible role of CYP3A4 and P-gp inhibition by HMG-CoA reductase inhibitorsSi-Hyung Yang, Jun-Shik Choi, Dong-Hyun Choi
Research Communications in Molecular Pathology and Pharmacology|July 13, 2004
Pharmacokinetics of tolbutamide after oral administration in rabbits with folate-induced renal failureHak Yeon Bae, Dong Hyun Choi, Jun Shik Choi
European Journal of Clinical Pharmacology|December 17, 2009
Pharmacokinetic interaction between oral lovastatin and verapamil in healthy subjects: role of P-glycoprotein inhibition by lovastatinDong-Hyun Choi, Joong-Hwa Chung, Jun-Shik Choi
Pharmacological Reports : PR|January 7, 2015
Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of nifedipine in rats: Possible role of P-gp and CYP3A4 inhibition by HMG-CoA reductase inhibitorsChong-Ki Lee, Jun-Shik Choi, Dong-Hyun Choi
Pageof 14